SPECIMEN COLLECTION AND PROCESSING FOR HEMOSTASIS Flashcards

(53 cards)

1
Q

SPECIMEN COLLECTION AND PROCESSING FOR HEMOSTASIS
General Considerations - Primary concern is to…

A

prevent premature activation of the clotting process

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Contamination with_____
Activates clotting early

A

tissue thromboplastin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

PROPER container:

A

Sodium Citrate (Light Blue Top)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Improper temperature

Labile Coagulation Factors at Room Temperature (20–24°C):

A

• Factor V (Labile Factor)
• Factor VIII (Anti-hemophilic Factor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Coagulation Factors Prematurely Activated at Refrigerated Temperature (below 20°C):

A

• Factor VII (Proconvertin)
• Factor XI (Plasma Thromboplastin Antecedent)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Causes of Hemolysis

A

• Prolonged tourniquet application (< 1 min.)
• Moisture or contamination
• Using needles with too small bore
• Frothing of sample due to air entry
• Expelling of blood from the syringes through the needle
• Excessive and vigorous mixing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

GENERAL CONSIDERATIONS
- primary concern is to prevent premature activation of the clotting process.

A
  1. Contamination with Tissue thromboplastin
  2. Inappropriate container
  3. Improper Temperature
  4. Hemolysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Needle Size - needles with _____are more likely to cause hemolysis

______- most commonly used for coagulation samples

______- collection of more than 20 mL of blood

______- narrow or small veins

A

small bores

20-gauge needle

19-gauge needle

21-gauge needles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Evacuated Tubes/ Syringes - should be______ coated

A

silicone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Evacuated tubes or syringes are silicone-coated to……

A

prevent platelet activation and clot formation during blood collection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Forms insoluble complexes or precipitates once recalcified and produces an interference in OD testing

A

Potassium Chloride

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Binds to calcium

A

Trisodium Citrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Trisodium Citrate ratio

A

9:1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Trisodium Citrate

Concentration:
_________ - (preferred)
_________- over anticoagulation for patients with high hematocrit

A

3.2% Na Citrate

3.8% Na Citrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Anticoagulant

Unsuitable for coagulation
Inhibits fibrinogen - thrombin reaction
• Factor V is suitable in its presence

A

EDTA (Ethylenediamine tetraacetic acid)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Factor______remains stable in the presence of EDTA, but since other steps are blocked, coagulation tests are still unreliable.

A

Factor V

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

• Acts with antithrombin Ill and inhibits all stages of coagulation

Can be used for platelet retention test

A

Heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Blood Collection
In performing venipuncture for coagulation testing, contamination of_______ and_____ is prevented.

• In the event of difficulty in blood collection, the attempt should be discontinued, then….

A

tissue factor and air

a new site must be chosen, and new blood collection equipment must be prepared for use.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Excessive redirection could lead to ______ and could cause the platelets to______ causing interference in tests

A

tissue damage

aggregate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

• For______ and_______, the vacuum tube method is acceptable if tissue juice contamination must be avoided.

In anticipation of difficulties while doing venipuncture or if blood is being drawn for special procedures, using______ method is recommended

A

Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT)

TWO-SYRINGE method

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Specimen Handling and Processing

EFFECTS OF pH
• Changes in pH can prolong clotting times
• Mediated by loss of CO2
• Samples should be_____ if immediate testing is not possible

TEMPERATURE
• Labile factor
• Prematurely activated @___deg C

CENTRIFUGATION
•____g for ___mins to obtain platelet poor plasma
• Only _____of plasma layer should be used for testing

A

unopened

4C

2000g for 10 mins

upper ¾

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

TEST FOR PRIMARY HEMOSTASIS
Involves:

A

PLATELET COUNT & FUNCTION and BLOOD VESSEL WALL

  1. Bleeding Time
  2. Capillary Resistance Test (Fragility Test)
  3. Clot Retraction Time
  4. Platelet count
  5. Platelet aggregation
  6. Platelet adhesiveness
23
Q

Primary hemostasis

A

The initial response to blood vessel injury, where platelets aggregate and adhere to the exposed collagen at the injury site.

24
Q

Primary hemostasis

Key Steps:

A
  1. Vasoconstriction: Blood vessels narrow to reduce blood flow.
  2. Platelet Adhesion: Platelets stick to the exposed collagen via von Willebrand factor (vWF).
  3. Platelet Activation: Platelets change shape and release substances to recruit more platelets.
  4. Platelet Aggregation: Platelets clump together, forming a temporary “platelet plug.”
25
Platelets INACTIVATED FORM of PLT: ACTIVATED FORM of PLT:
Round; Discoid shape Pseudopodia
26
Secondary hemostasis
This is the process that stabilizes and strengthens the initial platelet plug formed during primary hemostasis through the formation of a fibrin mesh.
27
Coagulation Factors Involved: 1. Intrinsic Pathway: Activated by damage to the blood vessel surface. • Factors: 2. Extrinsic Pathway: Activated by external trauma that exposes tissue factor (TF). • Factors: 3. Common Pathway: Both pathways converge to form a strong clot. • Factors:
XII, XI, IX, VIII VII X, V, II (Prothrombin), I (Fibrinogen), XIII
28
Secondary hemostasis End Result: • Formation of ______that weave through the platelet plug, making it stable and more resistant to breaking. • This solid clot helps to prevent further bleeding and promotes healing.
fibrin strands
29
The actual time it takes for a standard wound to stop bleeding ; Obsolete tests
Bleeding Time
30
DETECTS: Abnormalities of platelet number and function Factor VIII; vWF deficiency Abnormalities of vessel wall structure
Bleeding Time
31
Bleeding time METHODS (2)
Modified Duke Method Ivy Method
32
Bleeding time Modified Duke Method • Site:_____ • Tool:_____ • Procedure: • The blade punctures the earlobe and strikes a glass slide, producing a clicking sound. • Blood flow is monitored, and the time it takes to stop bleeding is recorded. • Normal Value (NV):_____
15–20 mm rounded fatty portion of the earlobe No. 11 sterile Bard-Parker Surgical Blade < 8 minutes
33
Bleeding time Ivy Method • Site:______ • Pressure: _____applied using a blood pressure cuff to maintain consistent pressure. • Procedure: • _____punctures are made on the forearm. • ______is used to blot the blood after______, then every_____ until bleeding stops.
Volar surface of the forearm 40 mmHg Two Filter paper 2 minutes 30 seconds
34
Detects abnormality of the capillaries due to a structural weakness in the capillary walls or thrombocytopenia; Abnormal in______ May be abnormal in (3)
Capillary Resistance Test (Fragility Test) hereditary telangiectasia hemophilia, Factor VII deficiency, and Vitamin K deficiency.
35
Capillary Resistance Test (Fragility Test) 2 METHODS
Positive pressure test/ Rumpel-Leede/ Tourniquet test Negative pressure test
36
Capillary Resistance Test (Fragility Test) Positive Pressure Test (Rumpel-Leede or Tourniquet Test) • Procedure: 1. Apply a _____to the upper arm. 2. Inflate to ____ (____for females). 3. Maintain the pressure for____ 4. Remove the cuff and observe for_____. Interpretation: • Normal:
blood pressure cuff 100 mmHg (80 mmHg) 5 minutes petechiae (small red or purple spots) formation Minimal or no petechiae.
37
Capillary Resistance Test (Fragility Test) Negative Pressure Test • Procedure: 1. A______ (____ in diameter) is applied to the midportion of the upper arm. 2. Apply a pressure of 200–250 torr for_____min/s. 3. Wait for_____, then count the petechiae. • Interpretation: • Normal:______
suction cup (2 cm) 200-250 torr for 1 minute 5 minutes Few or no petechiae.
38
Test for the time of the dissolution of the clot
Clot retraction time
39
Clot Retraction Time METHOD
McFarlane Clot Retraction Technique
40
Procedure (McFarlane Clot Retraction Technique): 1. Collect_____ of whole blood. 2. Incubate at____ for ____. 3. Observe as the clot shrinks and retracts from the tube walls. 4. The serum volume released from the clot is measured. Normal Values (NV): •_____ to _____ retraction is considered normal.
5 mL 37°C for 1 hour 44% to 67%
41
Formula for Clot Retraction Percentage (% CRT):
% CRT = (Volume of Serum/Total Volume of Whole Blood) x 100
42
Factors Affecting Clot Retraction: (3)
a. Number of contractible platelets b. Presence of calcium and ATP c. Normal concentration of fibrinogen
43
Platelet count DIRECT METHODS (3)
Tonkantin Method Brecker-Cronkite Method Unopette Method
44
Platelet count REFERENCE METHOD
Brecker-Cronkite Method
45
Diluent used Tonkantin Method Brecker-Cronkite Method Unopette Method
Rees-Ecker Diluting Fluid 1% Ammonium Oxalate Tripotassium EDTA + Ammonium Oxalate
46
Rees-Ecker Diluting Fluid (3) components
Na Citrate Formalin Brilliant Cresyl Blue
47
Platelet count PRINCIPLE: Hemolysis of red cells by hypotonicity and complete block of platelet activity by chelating Mg and Ca with EDTA and ammonium oxalate
Unopette Method
48
Platelet Aggregation Test Principle: • ______is mixed with aggregation agents. • These agents activate platelets, causing them to change ***shape and clump together (aggregate).*** • As aggregation occurs, the plasma becomes_____, allowing more light to pass through. • An_____ measures the increase in light transmission, indicating the degree of aggregation.
Platelet-Rich Plasma (PRP) clearer aggregometer
49
Platelet Aggregation Test AGGREGATION AGENTS:
Epinephrine Collagen ADP Ristocetin
50
Platelet Adhesiveness Test Principle: • The ______is used to assess platelet adhesiveness — the ability of platelets to stick to surfaces during blood flow. • When blood is passed through a glass bead column, platelets with normal_____ adhere and aggregate to the glass surface, mimicking how they attach to damaged blood vessels.
Glass Bead Test von Willebrand factor (vWF)
51
measures the ability of platelets to stick to surfaces (like blood vessel walls or glass beads).
Platelet adhesiveness
52
Platelet Adhesiveness Test PROCEDURE: 1. 1st sample is collected using____ tube 2. 2nd sample is collected using a____
EDTA tube glass bead collecting system
53
Platelet Adhesiveness Test FORMULA: NV:
PA=(PC1-PC2/PC1) X 100 70% or greater